Literature DB >> 11597360

Ultrasonographic assessment of coronary flow reserve and abdominal fat in obesity.

I Kondo1, K Mizushige, K Hirao, S Nozaki, T Tsuji, H Masugata, M Kohno, H Matsuo.   

Abstract

Recent technological advances in transthoracic Doppler echocardiography (TTDE) have provided noninvasive measurement of coronary flow velocity reserve (CFVR). We aimed to quantitate a correlation between endothelial dysfunction and fat distribution. In 36 patients with obesity, 16 with noninsulin-dependent diabetes mellitus (DM) and 12 healthy volunteers, coronary flow velocity was measured at the distal site of the left anterior descending branch. CFVR was defined as the ratio of hyperemic (IV infusion of 0.15 mg/kg/min adenosine) to basal peak diastolic flow velocity. Abdominal wall fat index (AWFI) was estimated by ultrasonography. Insulin resistance was quantified by the euglycemic hyperinsulinemic clump method. AWFI was significantly related to CFVR (r = -0.46, p = 0.011) and insulin resistance (r = -0.71, p < 0.0001). CFVR could be noninvasively evaluated using TTDE. Coronary endothelial dysfunction indicated as CFVR, body fat distribution and insulin resistance was quantitatively correlated in obesity.

Entities:  

Mesh:

Year:  2001        PMID: 11597360     DOI: 10.1016/s0301-5629(01)00427-6

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  8 in total

Review 1.  Heart of the matter: coronary dysfunction in metabolic syndrome.

Authors:  Zachary C Berwick; Gregory M Dick; Johnathan D Tune
Journal:  J Mol Cell Cardiol       Date:  2011-07-13       Impact factor: 5.000

2.  Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation.

Authors:  Léna Borbouse; Gregory M Dick; Gregory A Payne; Zachary C Berwick; Zachary P Neeb; Mouhamad Alloosh; Ian N Bratz; Michael Sturek; Johnathan D Tune
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-29       Impact factor: 4.733

Review 3.  Targeting abdominal obesity in cardiology: can we be effective?

Authors:  Paul Poirier
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

Review 4.  Capillary Rarefaction in Obesity and Metabolic Diseases-Organ-Specificity and Possible Mechanisms.

Authors:  Satu Paavonsalo; Sangeetha Hariharan; Madeleine H Lackman; Sinem Karaman
Journal:  Cells       Date:  2020-12-14       Impact factor: 6.600

Review 5.  Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation.

Authors:  Maarten M Brandt; Caroline Cheng; Daphne Merkus; Dirk J Duncker; Oana Sorop
Journal:  Front Physiol       Date:  2021-12-23       Impact factor: 4.566

6.  Insulin resistance and exercise tolerance in heart failure patients: linkage to coronary flow reserve and peripheral vascular function.

Authors:  Martin Snoer; Tea Monk-Hansen; Rasmus Huan Olsen; Lene Rørholm Pedersen; Lene Simonsen; Hanne Rasmusen; Flemming Dela; Eva Prescott
Journal:  Cardiovasc Diabetol       Date:  2012-08-13       Impact factor: 9.951

7.  Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease.

Authors:  Anders Jürs; Lene Rørholm Pedersen; Rasmus Huan Olsen; Martin Snoer; Elizaveta Chabanova; Steen Bendix Haugaard; Eva Prescott
Journal:  BMC Cardiovasc Disord       Date:  2015-11-27       Impact factor: 2.298

8.  Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function.

Authors:  Danijela Trifunovic; Sanja Stankovic; Dragana Sobic-Saranovic; Jelena Marinkovic; Marija Petrovic; Dejan Orlic; Branko Beleslin; Marko Banovic; Bosiljka Vujisic-Tesic; Milan Petrovic; Ivana Nedeljkovic; Jelena Stepanovic; Ana Djordjevic-Dikic; Milorad Tesic; Nina Djukanovic; Olga Petrovic; Olga Vasovic; Emilija Nestorovic; Jelena Kostic; Arsen Ristic; Miodrag Ostojic
Journal:  Cardiovasc Diabetol       Date:  2014-04-05       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.